-Assets Include Preclinical and Clinical Programs, Technology, Intellectual Property and Know-how-
-Completion of Sale Pending Certain Conditions-
-Company Continuing to Seek Strategic Alternatives, Including a Reverse Merger-
PR Newswire
LOS ANGELES, July 16, 2019